These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27738061)

  • 1. Validation of defibrillator lead performance registry data: insight from the Danish Pacemaker and ICD Register.
    Kristensen AE; Larsen JM; Nielsen JC; Johansen JB; Haarbo J; Petersen HH; Riahi S
    Europace; 2017 Jul; 19(7):1187-1192. PubMed ID: 27738061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary rates and outcomes of single- vs. dual-coil implantable cardioverter defibrillator lead implantation: data from the Israeli ICD Registry.
    Leshem E; Suleiman M; Laish-Farkash A; Konstantino Y; Glikson M; Barsheshet A; Goldenberg I; Michowitz Y;
    Europace; 2017 Sep; 19(9):1485-1492. PubMed ID: 27702848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable-Prévention Primaire registry.
    Defaye P; Boveda S; Klug D; Beganton F; Piot O; Narayanan K; Périer MC; Gras D; Fauchier L; Bordachar P; Algalarrondo V; Babuty D; Deharo JC; Leclercq C; Marijon E; Sadoul N;
    Europace; 2017 Sep; 19(9):1478-1484. PubMed ID: 28340096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable Cardioverter Defibrillator Lead Survival in Athletic Patients.
    Link MS; Sullivan RM; Olshansky B; Cannom D; Berul CI; Hauser RG; Heidbuchel H; Jordaens L; Krahn AD; Morgan J; Patton KK; Saarel EV; Wilkoff BL; Li F; Dziura J; Brandt C; Barth C; Lampert R
    Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009344. PubMed ID: 33724879
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Outcomes of Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: Lessons from the Israeli ICD Registry.
    Konstantino Y; Haim M; Boxer J; Goldenberg I; Feldman A; Michowitz Y; Glikson M; Suleiman M;
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):718-23. PubMed ID: 26852908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
    Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
    Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 12. Single-coil and dual-coil defibrillator leads and association with clinical outcomes in a complete Danish nationwide ICD cohort.
    Larsen JM; Hjortshøj SP; Nielsen JC; Johansen JB; Petersen HH; Haarbo J; Johansen MB; Thøgersen AM
    Heart Rhythm; 2016 Mar; 13(3):706-12. PubMed ID: 26593333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement.
    Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM
    Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience.
    Khazen C; Magnusson P; Flandorfer J; Schukro C
    Cardiol J; 2019; 26(5):543-549. PubMed ID: 29718532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter defibrillator patients: insight from Danish nationwide registers.
    Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Petersen HH; Torp-Pedersen C; Riahi S; Jøns C
    Europace; 2018 Feb; 20(2):301-307. PubMed ID: 28339659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients.
    Zhou Y; Zhao S; Chen K; Hua W; Zhang S
    BMC Cardiovasc Disord; 2019 May; 19(1):129. PubMed ID: 31146684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR.
    Kramer DB; Kennedy KF; Noseworthy PA; Buxton AE; Josephson ME; Normand SL; Spertus JA; Zimetbaum PJ; Reynolds MR; Mitchell SL
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):488-97. PubMed ID: 23759471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of single- vs dual-coil implantable defibrillator leads: An observational analysis from the SIMPLE study.
    Neuzner J; Hohnloser SH; Kutyifa V; Glikson M; Dietze T; Mabo P; Vinolas X; Kautzner J; O'Hara G; Lawo T; Brachmann J; VanErven L; Gadler F; Appl U; Wang J; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1078-1085. PubMed ID: 30945798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry.
    Steiner H; Geist M; Goldenberg I; Suleiman M; Glikson M; Tenenbaum A; Swissa M; Fisman EZ; Golovchiner G; Strasberg B; Barsheshet A;
    Cardiovasc Diabetol; 2016 Dec; 15(1):160. PubMed ID: 27905927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.